Improving diagnosis and prognosis of prostate cancer using advanced machine learning techniques
Robust and Interpretable Multimodal Machine Learning Models for Diagnosis and Prognosis of Prostate Cancer
This study is working on using smart computer technology to improve how doctors diagnose and predict prostate cancer, so patients can get more accurate results and better treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11045739 on NIH RePORTER |
What this research studies
This research focuses on enhancing the accuracy of prostate cancer diagnosis and prognosis through the use of advanced machine learning models. By integrating large imaging datasets with clinical scores, the project aims to develop robust frameworks that can better identify clinically significant prostate cancer. Patients will benefit from improved diagnostic tools that utilize deep learning architectures to analyze MRI images and other clinical data, potentially leading to more personalized treatment plans. The research will also address the challenges of over- and underdiagnosis that currently exist in standard diagnostic methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are American men who are at risk for prostate cancer or have been diagnosed with the disease.
Not a fit: Patients with prostate cancer who are not eligible for imaging studies or those with advanced metastatic disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of prostate cancer, improving treatment outcomes for patients.
How similar studies have performed: Other research has shown promising results using machine learning approaches for cancer diagnosis, indicating that this project builds on a foundation of successful methodologies.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Kim, Heejong — Weill Medical Coll of Cornell Univ
- Study coordinator: Kim, Heejong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.